SOCS6 expression is downregulated in CRC tissues and loss of SOCS6 contributes to enhanced oncogenic signalling, increased cell proliferation, and reduced apoptosis, promoting tumour growth and progression [16,57]. This evidence concerns the gene SOCS6 and neoplasm.